Post Marketing Surveillance of BI-Sifrol® (Pramipexole). Special Survey on Patients With Parkinson's Disease and Renal Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 12 Feb 2009 Actual initiation date (Feb 2004) added as reported by ClinicalTrials.gov.
- 09 Feb 2009 Planned number of patients changed from 100 to 107 as reported by ClinicalTrials.gov.
- 25 Feb 2008 New trial record.